---
title: "Fuan Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 113 million yuan, a decrease of 47.74%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254657239.md"
description: "According to the Zhitong Finance APP, Fuan Pharmaceutical released its semi-annual report for 2025, showing an operating income of 921 million yuan, a year-on-year decrease of 35.76%. The net profit attributable to shareholders of the listed company was 113 million yuan, a year-on-year decrease of 47.74%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 104 million yuan, a year-on-year decrease of 48.84%. The basic earnings per share were 0.1 yuan"
datetime: "2025-08-26T14:21:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254657239.md)
  - [en](https://longbridge.com/en/news/254657239.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254657239.md)
---

# Fuan Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 113 million yuan, a decrease of 47.74%

According to the Zhitong Finance APP, Fuan Pharmaceutical (300194.SZ) released its semi-annual report for 2025, reporting an operating income of 921 million yuan, a year-on-year decrease of 35.76%. The net profit attributable to shareholders of the listed company was 113 million yuan, a year-on-year decrease of 47.74%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 104 million yuan, a year-on-year decrease of 48.84%. The basic earnings per share were 0.1 yuan

### Related Stocks

- [300194.CN](https://longbridge.com/en/quote/300194.CN.md)

## Related News & Research

- [REG - BNP Paribas London Irish Continental - Form 8.3 BNPP AM EU Irish Continental Group plc](https://longbridge.com/en/news/295656014.md)
- [SHUKRAPHAR: Strong revenue and profit growth in Q1 FY27, with robust performance in the pharmaceutical segment](https://longbridge.com/en/news/295639972.md)
- [XCMG's Electric Mining Push Featured in The Australian Financial Review](https://longbridge.com/en/news/295381066.md)
- [MBF Group S.A. Calls Extraordinary General Meeting for September 2026](https://longbridge.com/en/news/295620354.md)
- [CTT Pharma wins US patent for micelle-based nicotine, vitamins, caffeine delivery technology](https://longbridge.com/en/news/295658829.md)